A detailed history of Tidemark, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Tidemark, LLC holds 50 shares of UTHR stock, worth $23,320. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50
Previous 80 37.5%
Holding current value
$23,320
Previous $22,000 9.09%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

SELL
$274.7 - $438.75 $8,241 - $13,162
-30 Reduced 37.5%
50 $20,000
Q2 2025

Aug 11, 2025

BUY
$276.47 - $328.4 $17,417 - $20,689
63 Added 370.59%
80 $22,000
Q1 2025

May 09, 2025

BUY
$304.42 - $380.78 $5,175 - $6,473
17 New
17 $5,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Tidemark, LLC Portfolio

Follow Tidemark, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tidemark, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tidemark, LLC with notifications on news.